Seer Inc (SEER)
2.42
+0.10
(+4.40%)
USD |
NASDAQ |
Nov 14, 16:00
2.42
0.00 (0.00%)
After-Hours: 16:58
Seer Total Assets (Quarterly): 383.42M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 383.42M |
| June 30, 2024 | 406.61M |
| March 31, 2024 | 421.96M |
| December 31, 2023 | 436.27M |
| September 30, 2023 | 444.85M |
| June 30, 2023 | 461.20M |
| March 31, 2023 | 472.79M |
| December 31, 2022 | 487.93M |
| September 30, 2022 | 500.21M |
| Date | Value |
|---|---|
| June 30, 2022 | 516.30M |
| March 31, 2022 | 527.08M |
| December 31, 2021 | 539.14M |
| September 30, 2021 | 527.84M |
| June 30, 2021 | 537.05M |
| March 31, 2021 | 545.64M |
| December 31, 2020 | 442.32M |
| September 30, 2020 | 133.89M |
| December 31, 2019 | 93.24M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
93.24M
Minimum
Dec 2019
545.64M
Maximum
Mar 2021
437.65M
Average
466.99M
Median
Total Assets (Quarterly) Benchmarks
| Organogenesis Holdings Inc | 443.16M |
| Poseida Therapeutics Inc | 298.69M |
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
| IGC Pharma Inc | 10.59M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 38.70M |
| Shareholders Equity (Quarterly) | 344.73M |
| Current Ratio | 18.36 |